Ligand Pharmaceuticals Incorporated (LGND) — Financial Flexibility Index
Ligand Pharmaceuticals Incorporated (LGND) has a Financial Flexibility Index of 0.02x as of June 2026. Free cash flow of $24.04 Million (operating CF $24.02 Million minus capex $26.00K) represents 0% of total liabilities ($1.22 Billion). Check Ligand Pharmaceuticals Incorporated total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ligand Pharmaceuticals Incorporated Financial Flexibility Index (1994–2025)
Historical Financial Flexibility Index trend for Ligand Pharmaceuticals Incorporated across 32 annual periods. For the full cash flow conversion analysis, see Ligand Pharmaceuticals Incorporated (LGND) cash flow conversion.
Annual Financial Flexibility Index for Ligand Pharmaceuticals Incorporated (1994–2025)
Year-by-year free cash flow to debt coverage for Ligand Pharmaceuticals Incorporated. Explore how well can Ligand Pharmaceuticals Incorporated service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.09x | $49.81 Million | $49.36 Million | $543.42 Million | ▼ -91.3% |
| 2024 | 1.05x | $116.69 Million | $97.05 Million | $111.33 Million | ▼ -12.5% |
| 2023 | 1.20x | $103.43 Million | $49.58 Million | $86.30 Million | ▲ +27.1% |
| 2022 | 0.94x | $155.77 Million | $137.85 Million | $165.18 Million | ▲ +413.1% |
| 2021 | 0.18x | $87.56 Million | $78.80 Million | $476.43 Million | ▲ +103.2% |
| 2020 | 0.09x | $59.04 Million | $54.59 Million | $652.76 Million | ▲ +345.8% |
| 2019 | -0.04x | $-26.78 Million | $-29.34 Million | $727.68 Million | ▼ -112.5% |
| 2018 | 0.29x | $205.95 Million | $194.06 Million | $699.89 Million | ▼ -26.3% |
| 2017 | 0.40x | $100.72 Million | $93.57 Million | $252.37 Million | ▲ +0.8% |
| 2016 | 0.40x | $91.32 Million | $63.00 Million | $230.73 Million | ▲ +72.8% |
| 2015 | 0.23x | $52.59 Million | $41.73 Million | $229.54 Million | ▲ +113.5% |
| 2014 | 0.11x | $25.07 Million | $20.57 Million | $233.62 Million | ▼ -76.9% |
| 2013 | 0.47x | $25.63 Million | $20.69 Million | $55.10 Million | ▲ +310.8% |
| 2012 | 0.11x | $8.80 Million | $161.00K | $77.78 Million | ▲ +1276.7% |
| 2011 | -0.01x | $-1.09 Million | $-1.17 Million | $113.70 Million | ▲ +97.1% |
| 2010 | -0.33x | $-27.00 Million | $-27.07 Million | $82.55 Million | ▼ -8.1% |
| 2009 | -0.30x | $-33.28 Million | $-33.80 Million | $109.95 Million | ▼ -173.4% |
| 2008 | -0.11x | $-20.13 Million | $-20.62 Million | $181.81 Million | ▲ +83.6% |
| 2007 | -0.67x | $-97.29 Million | $-97.73 Million | $144.16 Million | ▼ -47.4% |
| 2006 | -0.46x | $-136.74 Million | $-138.52 Million | $298.70 Million | ▼ -542.6% |
| 2005 | 0.10x | $43.96 Million | $8.37 Million | $425.04 Million | ▲ +350.7% |
| 2004 | 0.02x | $9.36 Million | $5.75 Million | $407.78 Million | ▲ +73.1% |
| 2003 | 0.01x | $3.06 Million | $274.00K | $230.53 Million | ▲ +111.9% |
| 2002 | -0.11x | $-21.95 Million | $-25.11 Million | $196.59 Million | ▼ -9.2% |
| 2001 | -0.10x | $-17.93 Million | $-19.91 Million | $175.35 Million | ▲ +62.7% |
| 2000 | -0.27x | $-46.27 Million | $-47.35 Million | $168.55 Million | ▼ -109.4% |
| 1999 | -0.13x | $-21.00 Million | $-60.50 Million | $160.20 Million | ▲ +65.8% |
| 1998 | -0.38x | $-64.20 Million | $-66.60 Million | $167.40 Million | ▼ -208.1% |
| 1997 | -0.12x | $-9.10 Million | $-13.40 Million | $73.10 Million | ▲ +74.4% |
| 1996 | -0.49x | $-32.90 Million | $-33.30 Million | $67.60 Million | ▲ +15.4% |
| 1995 | -0.58x | $-37.70 Million | $-37.90 Million | $65.50 Million | ▲ +14.3% |
| 1994 | -0.67x | $-13.70 Million | $-14.30 Million | $20.40 Million | — |